Efg Asset Management (North America) Corp. Rocket Pharmaceuticals, Inc. Transaction History
Efg Asset Management (North America) Corp.
- $568 Million
- Q1 2024
A detailed history of Efg Asset Management (North America) Corp. transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Efg Asset Management (North America) Corp. holds 151,002 shares of RCKT stock, worth $3.02 Million. This represents 0.72% of its overall portfolio holdings.
Number of Shares
151,002
Previous 155,205
2.71%
Holding current value
$3.02 Million
Previous $4.65 Million
12.56%
% of portfolio
0.72%
Previous 0.89%
Shares
6 transactions
Others Institutions Holding RCKT
# of Institutions
204Shares Held
92.9MCall Options Held
341KPut Options Held
107K-
Rtw Investments, LP New York, NY17.7MShares$354 Million7.65% of portfolio
-
Wellington Management Group LLP Boston, MA9.16MShares$183 Million0.04% of portfolio
-
Black Rock Inc. New York, NY5.93MShares$119 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.37MShares$108 Million0.0% of portfolio
-
State Street Corp Boston, MA4.19MShares$84 Million0.01% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $1.52B
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...